Skip to Main Content

Author Details

Dijana Djureinovic
Yale University School of Medicine
2014
26
15
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36821392Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.JCI Insight2023
37964379A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.Mol Cancer2023
37586773Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.J Immunother Cancer2023
37790306Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.Res Sq2023
37341056Expression of cancer-testis antigens in the immune microenvironment of non-small cell lung cancer.Mol Oncol2023
34140403A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1.Clin Cancer Res2021
33804039Agonistic CD40 Antibodies in Cancer Treatment.Cancers (Basel)2021
34339045Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.J Pathol2021
32028050WITHDRAWN: Characterization of Patterns of Immune Cell Infiltration in NSCLC.J Thorac Oncol2020
30639618Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.J Thorac Oncol2019
31357969Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung.BMC Cancer2019
29282718Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.J Pathol2018
30121393An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.J Thorac Oncol2018
30429015Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.Lung Cancer2018
29667169Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.Int J Cancer2018
27901589The Human Adrenal Gland Proteome Defined by Transcriptomics and Antibody-Based Profiling.Endocrinology2017
28281552Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.Mod Pathol2017
28664936PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability.Mod Pathol2017
28818916A pathology atlas of the human cancer transcriptome.Science2017
28052770A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.BMC Cancer2017
26872818The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.J Thorac Oncol2016
27699219Profiling cancer testis antigens in non-small-cell lung cancer.JCI Insight2016
25613900Proteomics. Tissue-based map of the human proteome.Science2015
24330150A systematic analysis of commonly used antibodies in cancer diagnostics.Histopathology2014
24309898Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.Mol Cell Proteomics2014
24598113The human testis-specific proteome defined by transcriptomics and antibody-based profiling.Mol Hum Reprod2014
  • 1 - 26 of 26

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 1
Mich??le Orain
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 0
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 2012
Number of shared co-authors 1
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2010
Number of shared co-authors 1
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 0
Fengshen Kuo
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Career Start Year 2003
Number of shared co-authors 0
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Wenyan Zhong
Oncology R&D
Career Start Year 2000
Number of shared co-authors 0
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 1
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 1
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 18
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 0
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 3

Collaborators

Patrick Micke
Uppsala University
Co-authored papers 15
Fredrik Pont??n
Uppsala University
Co-authored papers 13
Hans Brunnstr??m
Lund University
Co-authored papers 11
Cecilia Lindskog
Uppsala University
Co-authored papers 10
Johanna S M Mattsson
Uppsala University
Co-authored papers 9
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 8
Linn Fagerberg
KTH Royal Institute of Technology
Co-authored papers 6
Karin Jirstr??m
Lund University
Co-authored papers 6
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Co-authored papers 5
Harriet M Kluger
Yale School of Medicine
Co-authored papers 5
Bj??rn M Hallstr??m
Division of Clinical Genetics, Lund University
Co-authored papers 5
Per-Henrik Edqvist
Uppsala University
Co-authored papers 4
Sanjay Navani
Breach Candy Hospital and Research Centre
Co-authored papers 4
Jochen M Schwenk
KTH Royal Institute of Technology
Co-authored papers 4
Kalle von Feilitzen
KTH Royal Institute of Technology
Co-authored papers 3
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers 3
Evelina Sj??stedt
Karolinska Institutet
Co-authored papers 3
Adil Mardinoglu
Royal Institute of Technology Science for Life Laboratory Stockholm Sweden.
Co-authored papers 3
J??rg Rahnenf??hrer
TU Dortmund University
Co-authored papers 3
Peter Nilsson
Linkoping University
Co-authored papers 3
Julia Bergman
Uppsala University
Co-authored papers 3
??sa Sivertsson
KTH-Royal Institute of Technology
Co-authored papers 3
Per Oksvold
KTH-Royal Institute of Technology
Co-authored papers 3
Jenny Ottosson
Bio Pharmaceuticals R&D
Co-authored papers 2
Anna Asplund
Uppsala University
Co-authored papers 2
Caroline Kampf
Uppsala University
Co-authored papers 2
Michael E Hurwitz
Co-authored papers 2
Holger Berling
KTH-Royal Institute of Technology
Co-authored papers 2
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 2
Cristina Al-Khalili Szigyarto
KTH-Royal Institute of Technology
Co-authored papers 2
Release 1.2